Aetna — Merger or Acquisition (February 2018)
36 slides from Aetna's merger presentation, Feb 26, 2018
Slide 1: Fixed Income Presentation February 2018
Fixed Income Presentation February 2018 Filed by CVS Health Corporation Pursuant to Rule 425 under the Securities Act of 1933 And deemed filed pursuant to Rule 14a-12 Under the Securities Exchange Act of 1934 Subject Company: Aetna Inc. Commission File No.: 001-16095 Date: February 26, 2018
Slide 2: No Offer or Solicitation
No Offer or Solicitation This communication is for informational purposes only and not intended to and does not constitute an offer to subscribe for, buy or sell, the solicitation of an offer to subscribe for, buy or sell or an invitation to subscribe for, buy or sell any securities or the solicitat
Slide 3: Participants in Solicitation
Participants in Solicitation CVS Health, Aetna, their respective directors and certain of their respective executive officers may be considered participants in the solicitation of proxies in connection with the proposed transaction. Information about the directors and executive officers of CVS Healt
Slide 4: Forward-Looking Statements
Statements in this communication regarding CVS Health and Aetna that are forward-looking, including CVS Health’s and Aetna’s projections as to the closing date for the pending acquisition of Aetna (the “transaction”), the extent of, and the time necessary to obtain, the regulatory approvals required
Slide 5: Forward-Looking Statements (continued)
In addition, this communication may contain forward-looking statements regarding CVS Health’s or Aetna’s respective businesses, financial condition and results of operations. These forward-looking statements also involve risks, uncertainties and assumptions, some of which may not be presently known
Slide 6: Non-GAAP Financial Measures
Non-GAAP Financial Measures This presentation includes non-GAAP financial measures. For reconciliations of non-GAAP financial measures used in this presentation to the most directly comparable GAAP measures, please refer to the appendix. This communication shall not constitute or form part of an off
Slide 7: Agenda
Agenda CVS Health – Aetna Transaction Summary Overview of CVS Health Overview of Aetna Financial Overview
Slide 8: CVS Health – Aetna Transaction Summary
CVS Health – Aetna Transaction Summary
Slide 9: CVS Health – Aetna: Compelling Strategic Combination
CVS Health – Aetna: Compelling Strategic Combination Highly diversified, strong and stable cash flows Creates a leading health care platform with unmatched suite of services Improved quality of care through enhanced data integration / predictive analytics High-touch connectivity to consumers as go-t
Slide 10: Combination Expected to Help Address U.S. Health Care System Challenges
CVS Health-Aetna Combination Expected to Help Address U.S. Health Care System Challenges Growth in Health Care Expenditures Increasing Health Care Consumerism Movement To Value-Based Care Integrating medical and pharmacy benefits with consumer touchpoints to improve outcomes and lower costs Broad ma
Slide 11: To Compete in the Future, New Assets and Capabilities Required
To Compete in the Future, a Number of New Assets and Capabilities Will Be Required Additional capabilities required going forward Access to high-quality, lower-cost sites of care Lower-cost models of care delivery will be crucial given margin compression and shift to value-based care Winning in gove
Slide 12: CVS Health and Aetna Bring Unique and Differentiated Capabilities
World-class consumer health and engagement model Leading health financing platform Best-in-class service Targeted solutions to improve health and wellness Differentiated provider collaboration experience – equipping providers with tools to succeed Innovative plan designs Broad reach that positions u
Slide 13: Integrated Health Care Platform Offers Better Care at Lower Cost
Better clinical outcomes from combination of medical and pharmacy claims data Increased patient satisfaction from enhanced consumer engagement More convenient care from more localized access to care Lower cost to the patient and client Increased speed and efficiency of treatment Member and client be
Slide 14: Example: Better Manage Medical Cost for Chronic Patients
Example: CVS Health + Aetna Can Help Better Manage Medical Cost for Chronic Patients Pain points in current model Ways CVS Health + Aetna can improve Components of care delivery model Inconvenient and inaccessible health care delivery system Insufficient time to fully manage patient population Lack
Slide 15: Creating a New Sector Leader
Revenue, TTM as of 9/30/17 ($, billions) Comp A Comp B Comp C Comp D Comp E Comp F Creating a Fortune 4 company with over $200 billion of pro forma revenue Creating a New Sector Leader TTM figures for each company based on most recently reported company filings as of September 30, 2017 12
Slide 16: Overview of CVS Health
Overview of CVS Health {© 2018 CVS Health andor one ofits affites. vCVSHealth
Slide 17: Leadership Across Multiple Segments
Leadership Across Multiple Segments Retail Pharmacy Pharmacy Benefits Medicare Part D Specialty Pharmacy Senior-Care Pharmacy Retail Clinics More than 9,800 locations across 49 states, Washington D.C., Puerto Rico and Brazil Approximately 1.1 billion retail scripts filled annually(1) More than 94 mi
Slide 18: CVS Health Has A Leading Position in Specialty
Integrated Model Enables CVS Health to Meet the Needs of the Increasingly Complex Specialty Market Patient Payor Adherence to All Drugs Full Patient Management Easy, Local Access Price and Utilization Management Medical Benefit Management Site of Care Management PBM + Specialty Health Plan + PBM + S
Slide 19: Our Decade-Long Path of Transitioning into an Integrated Health Care Company
2015 2014 2013 2011 2007 2017 Our Decade-Long Path of Transitioning into an Integrated Health Care Company 2007: CVS Corp Acquires Caremark Rx CVS pioneers the integrated model Combined company is called CVS Caremark CVS Caremark strengthens position in medicare market 2011: CVS Caremark Acquires Me
Slide 20: Overview of Aetna
Overview of Aetna {© 2018 CVS Health andor one ofits affites. vCVSHealth
Slide 21: Aetna is a Leading Health Services Company
Serving an estimated 37.9M* people Leading Medicare Franchise Strong Clinical Assets Next Generation Capabilities *As of December 31, 2017 **Based on the Centers for Medicare & Medicaid Services (CMS) Medicare Five-Star Quality Rating System. Includes publicly traded companies with more than 250,000
Slide 22: Diversified Portfolio with a Strong National Footprint
2017 Revenue Mix 2017 Medical Membership Mix (at 12/31) Health insurer offering products in all 50 states Technology powering public and private insurance exchanges, helping consumers better understand, enroll in, and use their benefits Clinical and consumer analytics company that drives sustained e
Slide 23: Nationwide, Geographically Diverse Membership
Nationwide, Geographically Diverse Membership AZ TX LA FL IL KY OH MI WV PA NY NJ VA CA MD WA OR MT ID NV UT WY ND SD NE KS OK NM CO MN IA MO AR MS AL GA SC NC TN IN WI ME VT NH MA RI CT DE HI AK As of December 31, 2017, Aetna provided health benefits and services for ~22.2 million medical members a
Slide 24: Aetna's Extensive Next Generation Provider Network
Access to membership to increase provider engagement and collaboration Increase provider’s role to deliver consumer engagement and care model Align incentives and collaborate with providers to: Help providers build the health experience of the future Integrate data into EMR/provider workflows Improv
Slide 25: Financial Overview
Financial Overview {© 2018 CVS Health andor one ofits affites. vCVSHealth
Slide 26: Transaction Terms: Purchase Price, Ownership, Management and Financing
Equity value of $69 billion. Including the assumption of Aetna debt, total transaction value of $77 billion*. Approximately $207 per Aetna share in cash and stock, comprised of $145.00 per Aetna share in cash and 0.8378 in CVS Health shares per Aetna share* Purchase Price CVS Health shareholders wil
Slide 27: Sources and Uses of Funds
Sources ($B) Uses ($B) Available Cash 4.1 New Debt 44.8 New Equity Issued in Transaction 21.0 Total Sources 69.9 Purchase Equity* 69.2 Other 0.7 Total Uses 69.9 Sources and Uses of Funds *Based on CVS' 5-day Volume Weighted Average Price ending December 1, 2017 of $74.21 per share. 21
Slide 28: Continue to Execute Disciplined Long-Term Financial Policies
Leverage Focus on deleveraging to low 3x adj. debt-to-EBITDA ratio to maintain strong balance sheet Share Repurchases Suspend share repurchase program until leverage is down to low 3x Dividends Keep dividends per share flat until leverage is down to low 3x M&A Strategy No additional major transactio
Slide 29: Financial Performance Overview
CVS Health Revenue ($ billions) Adjusted EBITDA(1) ($ billions) Aetna Adjusted Revenue (1) ($ billions) Adjusted EBITDA (1) ($ billions) Financial Performance Overview Source: CVS Health and Aetna filings. Please refer to the reconciliations of these Non-GAAP Financial Measures to the most directly
Slide 30: Strong Balance Sheet with Focus on Deleveraging
Aetna CVS Health Post-Acquisition Structure $25.2bn existing public bonds as of 12/31/17 $9.2bn existing public bonds as of 12/31/17 Issuer of expected new debt Insurance OpCo CVS Health + Aetna Combined Debt Maturity Profile* Strong Liquidity CVS Health Commercial Paper Program:$4.5bn Backed by $4.
Slide 31: CVS Health – Aetna: Compelling Strategic Combination
CVS Health – Aetna: Compelling Strategic Combination Highly diversified, strong and stable cash flows Creates a leading health care platform with unmatched suite of services Improved quality of care through enhanced data integration / predictive analytics High-touch connectivity to consumers as go-t
Slide 32: Appendix
Appendix {© 2018 CVS Health andor one ofits affites. vCVSHealth
Slide 33: Non-GAAP Reconciliation – CVS Health Adjusted EBITDA
Non-GAAP Reconciliation – CVS Health Adjusted EBITDA Source: Company filings. For the years ended December 31, 2016 and 2015 depreciation and amortization includes $30 million and $11 million, respectively, of acquisition-related integration depreciation. The depreciation and amortization relate to
Slide 34: Non-GAAP Reconciliation – CVS Health Free Cash Flow
Non-GAAP Reconciliation – CVS Health Free Cash Flow Source: Company filings. 27
Slide 35: Non-GAAP Reconciliation – Aetna Adjusted EBITDA
Non-GAAP Reconciliation – Aetna Adjusted EBITDA Source: Aetna filings. 28
Slide 36: Non-GAAP Reconciliation – Aetna Adjusted Revenue
Non-GAAP Reconciliation – Aetna Adjusted Revenue Source: Aetna filings. 29